Active Ingredient History
Sotagliflozin, sold under the brand name Inpefa among others, is a medication used to reduce the risk of death due to heart failure. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Albuminuria (Phase 4)
Blood Glucose (Phase 3)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 1 (Phase 4)
Diabetes Mellitus, Type 2 (Phase 3)
Diabetic Nephropathies (Phase 4)
Healthy Volunteers (Phase 1)
Heart Failure (Phase 3)
Heart Failure, Diastolic (Phase 4)
Hypoxia (Phase 4)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 1)
Liver Diseases (Phase 1)
Renal Insufficiency, Chronic (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue